Cover

Pediatric Neuroendocrinology

Editor(s): Loche S. (Cagliari) 
Cappa M. (Rome) 
Ghizzoni L. (Turin) 
Maghnie M. (Genova) 
Savage M.O. (London) 
Table of Contents
Vol. 17, No. , 2010
Section title: Paper
Loche S, Cappa M, Ghizzoni L, Maghnie M, Savage MO (eds): Pediatric Neuroendocrinology. Endocr Dev. Basel, Karger, 2010, vol 17, pp 11–21
(DOI:10.1159/000262524)

Role of Sleep and Sleep Loss in Hormonal Release and Metabolism

Leproult R. · Van Cauter E.
Department of Medicine, University of Chicago, Chicago, Ill., USA

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Compared to a few decades ago, adults, as well as children, sleep less. Sleeping as little as possible is often seen as an admirable behavior in contemporary society. However, sleep plays a major role in neuroendocrine function and glucose metabolism. Evidence that the curtailment of sleep duration may have adverse health effects has emerged in the past 10 years. Accumulating evidence from both epidemiologic studies and well-controlled laboratory studies indicates that chronic partial sleep loss may increase the risk of obesity and weight gain. The present chapter reviews epidemiologic studies in adults and children and laboratory studies in young adults indicating that sleep restriction results in metabolic and endocrine alterations, including decreased glucose tolerance, decreased insulin sensitivity, increased evening concentrations of cortisol, increased levels of ghrelin, decreased levels of leptin and increased hunger and appetite. Altogether, the evidence points to a possible role of decreased sleep duration in the current epidemic of obesity. Bedtime extension in short sleepers should be explored as a novel behavioral intervention that may prevent weight gain or facilitate weight loss. Avoiding sleep deprivation may help to prevent the development of obesity, particularly in children.



 goto top of outline Author Contacts

Eve Van Cauter, PhD, Department of Medicine, MC1027, 5841 S. Maryland Avenue, Chicago, IL 60637 (USA), Tel. +1 773 702 0169, Fax +1 773 702 7686, E-Mail evcauter@medicine.bsd.uchicago.edu


 goto top of outline Article Information

Number of Print Pages : 11


 goto top of outline Publication Details

Book Serie: Endocrine Development, Vol. 17, Year 2010

Editor(s): Loche, S. (Cagliari); Cappa, M. (Rome); Ghizzoni, L. (Turin); Maghnie, M. (Genova); Savage, M.O. (London)
ISSN: 1421-7082 (Print), eISSN: 1662-2979 (Online)

For additional information:
http://content.karger.com/ProdukteDB/produkte.asp?issn=1421-7082

Book Title: Pediatric Neuroendocrinology (Workshop, Villasimius, May 2009)

Editor(s): Loche S, Cappa M, Ghizzoni L, Maghnie M, Savage MO (eds)

For additional information:
http://content.karger.com/ProdukteDB/produkte.asp?issn=1421-7082&volume=17


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Van Cauter E, Copinschi G: Endocrine and other biological rhythms. (eds) DeGroot L, Jameson J: Endocrinology Philadelphia, Saunders, 2006;235-256
  2. Welsh DK, et al: Individual neurons dissociated from rat suprachiasmatic nucleus express independently phased circadian firing rhythms. Neuron 1995;14:697-706
  3. Lowrey PL, Takahashi JS: Mammalian circadian biology: elucidating genome-wide levels of temporal organization. Annu Rev Genomics Hum Genet 2004;5:407-441
  4. Vitaterna M, Pinto L, Turek F: Molecular genetic basis for mammalian circadian rhythms. (eds) Kryger MH, Dement WC: Principles and Practices of Sleep Medicine 4New York, Saunders, 2005;363-374
  5. Landolt HP: Sleep homeostasis: a role for adenosine in humans?. Biochem Pharmacol 2008;75:2070-2079
  6. Porkka-Heiskanen T, et al: Adenosine: A mediator of the sleep-inducing effects of prolonged wakefulness. Science 1997;276:1255-1258
  7. Retey JV, et al: A functional genetic variation of adenosine deaminase affects the duration and intensity of deep sleep in humans. Proc Natl Acad Sci USA 2005;102:15676-15681
  8. Benington JH, Heller HC: Restoration of brain energy metabolism as the function of sleep. Prog Neurobiol 1995;45:347-360
  9. Tononi G, Cirelli C: Sleep function and synaptic homeostasis. Sleep Med Rev 2006;10:49-62
  10. Van Cauter E, et al: Modulation of glucose regulation and insulin secretion by circadian rhythmicity and sleep. J Clin Invest 1991;88:934-942
  11. Simon C, et al: Slow oscillations of plasma glucose and insulin secretion rate are amplified during sleep in humans under continuous enteral nutrition. Sleep 1994;17:333-338
  12. Centers for Disease Control and Prevention. Prevalence of Overweight Among Children and Adolescents: United States, 2003-2004 [online]. 2007 [cited April 12, 2008]; Available from: http://www.cdc.gov/nchs/products/pubs/pubd/hestats/over-weight/overwght_child_03.htm
  13. Keith SW, et al: Putative contributors to the secular increase in obesity: exploring the roads less traveled. Int J Obes (Lond) 2006;30:1585-1594
  14. National Sleep Foundation: Sleep in America Poll. Washington, 2008;
  15. Kripke D, et al: Short and long sleep and sleeping pills. Is increased mortality associated?. Arch Gen Psychiatry 1979;36:103-116
  16. Carskadon MA, Acebo C: Regulation of sleepiness in adolescents: update, insights, and speculation. Sleep 2002;25:606-614
  17. National Sleep Foundation: Sleep in America Poll. Washington, 2006;
  18. Lumeng JC, et al: Shorter sleep duration is associated with increased risk for being overweight at ages 9 to 12 years. Pediatrics 2007;120:1020-1029
  19. Agras WS, et al: Risk factors for childhood overweight: a prospective study from birth to 9.5 years. J Pediatr 2004;145:20-25
  20. Reilly J, et al: Early life risk factors for obesity in childhood: cohort study. Br Med J 2005;330:1357
  21. Taveras EM, et al: Short sleep duration in infancy and risk of childhood overweight. Arch Pediatr Adolesc Med 2008;162:305-311
  22. Touchette E, et al: Associations between sleep duration patterns and overweight/obesity at age 6. Sleep 2008;31:1507-1514
  23. Sugimori H, et al: Analysis of factors that influence body mass index from ages 3 to 6 years: a study based on the Toyama cohort study. Pediatr Int 2004;46:302-310
  24. Snell EK, Adam EK, Duncan GJ: Sleep and the body mass index and overweight status of children and adolescents. Child Dev 2007;78:309-323
  25. Knutson KL, Van Cauter E: Associations between sleep loss and increased risk of obesity and diabetes. Ann NY Acad Sci 2008;1129:287-304
  26. Spiegel K, Leproult R, Van Cauter E: Impact of sleep debt on metabolic and endocrine function. Lancet 1999;354:1435-1439
  27. Spiegel K, et al: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels and increased hunger and appetite. Ann Intern Med 2004;141:846-850
  28. Nedeltcheva AV, Kilkus JM, Imperial J, Kasza K, Schoeller DA, Penev PD: Sleep curtailment is accompanied by increased intake of calories from snacks. Am J Clin Nutr 2009;89:126-133
  29. Spiegel K, et al: Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes. J Appl Physiol 2005;99:2008-2019
  30. Buxton O, et al: Sleep restriction for one week reduces insulin sensitivity measured using the euglycemic hyperinsulinemic clamp technique. Sleep 2008;31:A107
  31. Tasali E, et al: Slow-wave sleep and the risk of type 2 diabetes in humans. Proc Natl Acad Sci USA 2008;105:1044-1049


Pay-per-View Options
Direct payment This item at the regular price: USD 33.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 23.00